An effectiveness and cost analysis of presumptive treatment for Mycobacterium tuberculosis

American Journal of Infection Control

Volumn 26, Issue 3, 1998, Pages 232-238

  Brewer, T F ^a   Heymann, S J ^a   Ettling, M ^a  

^a CHANNING LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ACID FAST BACTERIUM; ARTICLE; COST BENEFIT ANALYSIS; FATALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MORTALITY; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

EID: 0031806747     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-6553(98)80006-0     Document Type: Article

References (44)

1. Centers for Disease Control and Prevention Expanded tuberculosis surveillance and tuberculosis morbidity—United States, 1993 MMWR Morb Mortal Wkly Rep 43 1994 361 366
2. Bloch AB Cauthen GM Onorato IM Nationwide survey of drug resistant tuberculosis in the United States JAMA 271 1994 665 671
3. [published erratum appears in N Engl J Med 1993;329:148] Frieden TR Sterling T Pablos-Mendez A Kilburn JO Cauthen GM Dooley SW The emergence of drug-resistant tuberculosis in New York City N Engl J Med 328 1993 521 526
4. Brudney K Dobkin J A tale of two cities: tuberculosis control in Nicaragua and New York City Semin Respir Infect 6 1991 261 272
5. Centers for Disease Control National action plan to combat multidrug-resistant tuberculosis MMWR Morb Mortal Wkly Rep 41 RR-11 1992 1 30
6. Centers for Disease Control Initial therapy for tuberculosis in the era of multidrug resistance: recommendations of the Advisory Council for the Elimination of Tuberculosis MMWR Morb Mortal Wkly Rep 42 1993 1 8
7. Kopanoff DE Snider DE Caras GJ Isoniazid-related hepatitis: a U.S. Public Health Service Cooperative Surveillance Study Am Rev Respir Dis 117 1978 991 1001
8. Centers for Disease Control and Prevention Severe isoniazid-associated hepatitis—New York 1991–1993 MMWR Morb Mortal Wkly Rep 42 1993 545 547
9. Tenover FC Crawford JT Huebner RE Geiter LJ Horsburgh CR Good RC The resurgence of tuberculosis: Is your laboratory ready? J Clin Microbiol 31 1993 767 770
10. American Thoracic Society Treatment of tuberculosis and tuberculosis infection in adults and children Am J Respir Crit Care Med 149 1994 1359 1374
11. Centers for Disease Control and Prevention Initial therapy for tuberculosis in the era of multidrug resistance MMWR Morb Mortal Wkly Rep 42 RR-7 1993 1 8
12. Forbes BA Hicks KES Direct detection of Mycobacterium tuberculosis in respiratory specimens in a clinical laboratory by polymerase chain reaction J Clin Microbiol 31 1993 1688 1694
13. Miller N Hernandez SG Cleary TJ Evaluation of Gen-Probe amplified Mycobacterium tuberculosis direct test and PCR for direct detection of Mycobacterium tuberculosis in clinical specimens J Clin Microbiol 32 1994 393 397
14. Kirihara JM Hillier SL Coyle MB Improved detection times for Mycobacterium avium and Mycobacterium tuberculosis with BACTEC radiometric system J Clin Microbiol 22 1985 841 845
15. Good RC Isolation of nontuberculous mycobacteria in the United States, 1979 J Infect Dis 142 1980 779 783
16. Weinstein MC Fineberg HV Clinical decision analysis 1980 WB Saunders Philadelphia 37 40
17. Iseman MD Treatment of multidrug resistant tuberculosis N Engl J Med 329 1993 784 791
18. U.S. Department of Commerce 113th ed Statistical Abstract of the United States 1993
19. Thompson NJ Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up of the IUAT trial Bull World Health Organ 60 1982 555 564
20. Cohn DL Catlin BJ Peterson KL Judson FN Sbarbaro JA A 62 dose, 6 month therapy for pulmonary and extrapulmonary tuberculosis: a twice-weekly, directly observed, and cost-effective regimen Ann Intern Med 112 1990 407 415
21. Goble M Iseman MD Madsen LA Waite D Ackerson L Horsburgh CR Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin N Engl J Med 328 1993 527 532
22. National Tuberculosis Institute, Bangalore Tuberculosis in a rural population of South India: a five-year epidemiological study Bull World Health Organ 51 1974 473 488
23. Combs DL O'Brien RJ Geiter LJ USPHS tuberculosis short-course chemotherapy trial 21: effectiveness, toxicity, and acceptability Ann Intern Med 112 1990 397 406
24. Hong Kong Tuberculosis Treatment Services/British Medical Research Council Adverse reactions to short-course regimens containing streptomycin, isoniazid, pyrazinamide and rifampicin in Hong Kong Tubercle 57 1976 81 95
25. Zierski M Bek E Side-effects of drug regimens used in short-course chemotherapy for pulmonary tuberculosis: a controlled clinical study Tubercle 61 1980 41 49
26. Denver National Jewish Center for Immunology and Respiratory Medicine Charges for procedures 1994
27. Massachusetts Department of Public Health listing of state payments for treatment of clinic-based TB cases 1993
28. Snider DE Caras GJ Koplan JP Preventive therapy with isoniazid JAMA 255 1986 1579 1583
29. Mahmoudi A Iseman MD Pitfalls in the care of patients with tuberculosis JAMA 270 1993 65 68
30. Small PM Schecter GF Goodman PC Sande MA Chaisson RE Hopewell PC Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection N Engl J Med 324 1991 289 294
31. Tengs TO Adams ME Pliskin JS Five-hundred lifesaving interventions and their cost-effectiveness Risk Analysis 15 1995 369 390
32. Clarridge JE Shawar RM Shinnick TM Plikaytis BB Large-scale use of PCR for detection of Mycobacterium tuberculosis in a routine mycobacteriology laboratory J Clin Microbiol 31 1993 2049 2056
33. Elliott AM Namaambo K Allen BW Negative sputum smear results in HIV-positive patients with pulmonary tuberculosis in Lusaka, Zambia Tubercle Lung Dis 74 1993 191 194
34. Kiehn TE Cammarata R Laboratory diagnosis of mycobacterial infection in patients with AIDS J Clin Microbiol 24 1986 708 711
35. Stager CE Libonati JP Siddiqi SH Role of solid media when used in conjunction with the BACTEC system for mycobacterial isolation and identification J Clin Microbiol 29 1991 154 157
36. Salfinger M Demchuk BS Kafader FM Comparison between the MB check broth, radiometric, and conventional methods for recovery of mycobacteria from respiratory specimens J Microbiol Methods 12 1990 97 100
37. D'Amato RF Isenberg HD Hochstein L Mastellone AJ Alperstein P Evaluation of the Roche Septi-Chek AFB system for recovery of mycobacteria J Clin Microbiol 29 1991 2906 2908
38. Sewell DL Comparison of the Septi-Chek AFB and BACTEC Systems and conventional culture for recovery of mycobacteria J Clin Microbiol 31 1993 2689 2691
39. Anargyros P Astill DSJ Lim ISL Comparison of improved BACTEC and Lowenstein-Jensen media for culture of mycobacteria from clinical specimens J Clin Microbiol 28 1990 1288 1291
40. Roberts GD Goodman NL Heifets L Evaluation of the BACTEC radiometric method for recovery of mycobacteria and drug susceptibility testing of Mycobacterium tuberculosis from acid-fast smear-positive specimens J Clin Microbiol 18 1983 689 697
41. Salomon N Perlman DC Friedmann P Buchstein S Kreiswirth BN Mildvan D Predictors and outcome of multidrug-resistant tuberculosis Clin Infect Dis 21 1995 1245 1252
42. Fischl MA Daikos GL Uttamchandani RB Clinical presentation and outcome of patients with HIV infection and tuberculosis caused by multiple-drug-resistant bacilli Ann Intern Med 117 1992 184 190
43. Osmond D Charlebois E Lang W Shiboski S Moss A Changes in AIDS survival time in two San Francisco cohorts of homosexual men, 1983 to 1993 JAMA 271 1994 1083 1087
44. Centers for Disease Control and Prevention Tuberculosis program management report case register for calendar 1992